Chris de Mauny

I am a patent litigation specialist based in San Francisco. I advise clients from a range of industries including tech, life sciences and sustainable technologies.

I advise on all forms of intellectual property litigation, principally patents. In 2018 I was identified as a 'rising star' for patent litigation by Managing Intellectual Property and again in 2019. In 2019 I was referred to as a 'key lawyer' within Bird & Bird's London patent litigation team by Legal 500. In 2020 I was recognised as a 'Rising Star' for patents by Expert Guides, a peer-nominated international guide to lawyers, Legal 500 and MIP. Since becoming a partner I have been ranked or recommended by IAM, MIP and Legal 500.

I was called to the Bar in 2006 and practised in specialist intellectual property chambers until early 2011 when I joined Bird & Bird, known for its focus on technology clients. Bird & Bird received Managing Intellectual Property's 'Law Firm of the Decade - Europe' award in 2015 and is one of only two firms in the top ranking for IP by Chambers Global.

I have represented a range of clients from multinational corporations to individual traders in disputes involving patents, trade marks and passing off, design rights, copyright, and rights in confidential and/or private information. My recent work has focused primarily on patent litigation in the life sciences, electronics and sustainable technologies.

On 1 April 2024 I relocated to San Francisco to co-head Bird & Bird's representative office which brings our European and Asia-Pac expertise to US soil.

I am a member of EPLAW, the IP Bar Association, CIPA and AIPPI.

• Current and previous clients include:
• BAE Systems (helmet-mounted displays for fighter jets)
• Baxter Healthcare (dialysis machines)
• The Broad Institute (CRISPR)
• BT (DSL line management systems)
• Celltrion (biosimilar launch projects)
• Dexcom (continuous glucose monitoring systems)
• Dr Reddy's Laboratories (buprenorphine patches)
• EMGS (EM-based sub-sea surveying technology)
• Honeywell (HFOs)
• Johnson Matthey (chemical tracers)
• Nokia (NSEPs)
• Sarepta (Exondys 51)
• Teva (Copaxone and others)
• Qualcomm (SEPs)